1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue
1.4 Market Analysis by Type
1.4.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 AAV
1.4.3 Adenoviral
1.4.4 Lentiviral
1.4.5 Retroviral
1.4.6 Plasmid DNA
1.4.7 Other Vectors
1.5 Market by Application
1.5.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Application: 2021-2026
1.5.2 Cancers
1.5.3 Inherited Disorders
1.5.4 Viral Infections
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market
1.8.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Market Share by Region (2015-2020)
3.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Revenue Market Share by Region (2015-2020)
3.3 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume
3.3.1 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Growth Rate (2015-2020)
3.3.2 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume
3.4.1 East Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume (2015-2020)
3.5.1 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume (2015-2020)
3.6.1 South Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume (2015-2020)
3.7.1 Southeast Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume (2015-2020)
3.8.1 Middle East Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume (2015-2020)
3.9.1 Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume (2015-2020)
3.10.1 Oceania Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume (2015-2020)
3.11.1 South America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Growth Rate (2015-2020)
3.11.2 South America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume (2015-2020)
3.12.1 Rest of the World Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Volume Market Share by Type (2015-2020)
14.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Revenue Market Share by Type (2015-2020)
14.3 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Consumption Volume by Application (2015-2020)
15.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business
16.1 BioReliance
16.1.1 BioReliance Company Profile
16.1.2 BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.1.3 BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Richter-Helm
16.2.1 Richter-Helm Company Profile
16.2.2 Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.2.3 Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 UniQure
16.3.1 UniQure Company Profile
16.3.2 UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.3.3 UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Cobra Biologics
16.4.1 Cobra Biologics Company Profile
16.4.2 Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.4.3 Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 MassBiologics
16.5.1 MassBiologics Company Profile
16.5.2 MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.5.3 MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Oxford BioMedica
16.6.1 Oxford BioMedica Company Profile
16.6.2 Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.6.3 Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Lonza
16.7.1 Lonza Company Profile
16.7.2 Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.7.3 Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 MolMed
16.8.1 MolMed Company Profile
16.8.2 MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.8.3 MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 FinVector
16.9.1 FinVector Company Profile
16.9.2 FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.9.3 FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 FUJIFILM Diosynth Biotechnologies
16.10.1 FUJIFILM Diosynth Biotechnologies Company Profile
16.10.2 FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.10.3 FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Brammer Bio
16.11.1 Brammer Bio Company Profile
16.11.2 Brammer Bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.11.3 Brammer Bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 bluebird bio
16.12.1 bluebird bio Company Profile
16.12.2 bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.12.3 bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Aldevron
16.13.1 Aldevron Company Profile
16.13.2 Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.13.3 Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Spark Therapeutics
16.14.1 Spark Therapeutics Company Profile
16.14.2 Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.14.3 Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 VGXI
16.15.1 VGXI Company Profile
16.15.2 VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.15.3 VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 Biovian
16.16.1 Biovian Company Profile
16.16.2 Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.16.3 Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.17 Eurogentec
16.17.1 Eurogentec Company Profile
16.17.2 Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.17.3 Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.18 Novasep
16.18.1 Novasep Company Profile
16.18.2 Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.18.3 Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.19 PlasmidFactory
16.19.1 PlasmidFactory Company Profile
16.19.2 PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.19.3 PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.20 Cell and Gene Therapy Catapult
16.20.1 Cell and Gene Therapy Catapult Company Profile
16.20.2 Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.20.3 Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.21 Vigene Biosciences
16.21.1 Vigene Biosciences Company Profile
16.21.2 Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Specification
16.21.3 Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Manufacturing Cost Analysis
17.1 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing
17.4 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Distributors List
18.3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing (2021-2026)
20.2 Global Forecasted Revenue of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing (2021-2026)
20.3 Global Forecasted Price of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing (2015-2026)
20.4 Global Forecasted Production of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing by Region (2021-2026)
20.4.1 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production, Revenue Forecast (2021-2026)
20.4.3 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production, Revenue Forecast (2021-2026)
20.4.7 Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production, Revenue Forecast (2021-2026)
20.4.9 South America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing by Country
21.2 East Asia Market Forecasted Consumption of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing by Country
21.3 Europe Market Forecasted Consumption of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing by Countriy
21.4 South Asia Forecasted Consumption of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing by Country
21.5 Southeast Asia Forecasted Consumption of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing by Country
21.6 Middle East Forecasted Consumption of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing by Country
21.7 Africa Forecasted Consumption of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing by Country
21.8 Oceania Forecasted Consumption of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing by Country
21.9 South America Forecasted Consumption of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing by Country
21.10 Rest of the world Forecasted Consumption of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer